(2015; 93 pages)
This National Medicines Policy (NMP) is the overall policy document for the Afghanistan pharmaceutical sector. It constitutes part of the continuous efforts by the Ministry of Public Health (MoPH) and its stakeholders to ensure the availability, accessibility, affordability, and rational use of safe, efficacious, and quality medicines. The NMP aims to guide the provision of comprehensive pharmaceutical services as a major component of health promotion as well as preventive, curative, rehabilitative, and palliative care. It also represents a commitment to building a responsive, sustainable, and viable pharmaceutical industry.
The policy comprehensively covers medicines regulation, quality assurance, selection, supply, and rational use. It reviews mechanisms to secure sustainable financing, build local human capacity for services, and manufacture essential and complementary medicines. Strategies for international cooperation and systems for monitoring and evaluating are also described.
This edition of the NMP was developed through a systematic process, as internationally established. A NMP Task Force (NMPTF) comprised of key technical stakeholders was established under the direct supervision and leadership of MoPH. The NMPTF consulted widely and reviewed the current pharmaceutical situation in Afghanistan. An initial draft policy document was developed and subjected to widespread consultation with stakeholders, both internally and externally. The final draft document was compiled and presented to MoPH, which took the final decision on all aspects of the policy and approved it for implementation. This policy document will be complemented by a National Pharmaceutical Master Plan (NPMP), which will set out strategies, objectives, activities, and expected outcomes/outputs to implement all components of the NMP.